NEW ENTERPRISE ASSOCIATES 13, L.P. / SAGIMET BIOSCIENCES -- 13G

Company

Sagimet Biosciences Inc.

Filed

February 14, 2024

Accession Number

0001072613-24-000258

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →